CO6801767A2 - Formulaciones de liberación sostenida de paracetamol - Google Patents

Formulaciones de liberación sostenida de paracetamol

Info

Publication number
CO6801767A2
CO6801767A2 CO13259868A CO13259868A CO6801767A2 CO 6801767 A2 CO6801767 A2 CO 6801767A2 CO 13259868 A CO13259868 A CO 13259868A CO 13259868 A CO13259868 A CO 13259868A CO 6801767 A2 CO6801767 A2 CO 6801767A2
Authority
CO
Colombia
Prior art keywords
sustained
release formulations
paracetamol
paracetamol release
formulations
Prior art date
Application number
CO13259868A
Other languages
English (en)
Inventor
Carla Valenti Buan
Dongzhou Liu
Kanji Meghpara
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of CO6801767A2 publication Critical patent/CO6801767A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CO13259868A 2011-05-06 2013-11-01 Formulaciones de liberación sostenida de paracetamol CO6801767A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161483320P 2011-05-06 2011-05-06

Publications (1)

Publication Number Publication Date
CO6801767A2 true CO6801767A2 (es) 2013-11-29

Family

ID=47139543

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13259868A CO6801767A2 (es) 2011-05-06 2013-11-01 Formulaciones de liberación sostenida de paracetamol

Country Status (19)

Country Link
US (1) US20140065213A1 (es)
EP (1) EP2704697B1 (es)
CN (1) CN103648486A (es)
AP (1) AP3878A (es)
AU (1) AU2012253834B2 (es)
BR (1) BR112013028668A2 (es)
CA (1) CA2835330A1 (es)
CL (1) CL2013003176A1 (es)
CO (1) CO6801767A2 (es)
CR (1) CR20130572A (es)
DO (1) DOP2013000258A (es)
EA (1) EA201391643A1 (es)
GT (1) GT201300270A (es)
MX (1) MX2013012918A (es)
NI (1) NI201300116A (es)
SG (1) SG194605A1 (es)
TW (1) TW201306881A (es)
WO (1) WO2012154563A1 (es)
ZA (1) ZA201308316B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TW201507726A (zh) * 2013-05-10 2015-03-01 Glaxosmithkline Llc 菸鹼菱形錠配製物
BE1021194B1 (nl) * 2014-07-07 2015-07-14 Nordic Specialty Pharma Bvba Paracetamol tabletten
JP6772430B2 (ja) 2015-03-03 2020-10-21 サニオナ・エー／エス テソフェンシンとベータブロッカーの合剤
BE1023116B1 (nl) * 2015-07-24 2016-11-23 Nordic Specialty Pharma Bvba Paracetamol omvattend preparaat met vertraagde en aanhoudende afgifte

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US20030064108A1 (en) * 1996-04-23 2003-04-03 Stefan Lukas Taste masked pharmaceutical compositions
AUPN940796A0 (en) * 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
ES2237163T3 (es) * 1998-10-01 2005-07-16 Novartis Ag Nuevas formulaciones orales de revastigmina de liberacion controlada.
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
EP1519717B1 (en) * 2002-07-05 2010-09-29 Temrel Limited Controlled release composition
US20080031901A1 (en) * 2004-09-24 2008-02-07 Abbott Laboratories Sustained release monoeximic formulations of opioid and nonopioid analgesics
CN102697704A (zh) * 2003-09-26 2012-10-03 阿尔扎公司 阿片类与非阿片类镇痛药的控释制剂
PT1781277E (pt) * 2004-07-07 2012-05-07 Aft Pharmaceuticals Ltd Composição combinada
EP2271330A1 (en) * 2008-02-01 2011-01-12 Abbott Laboratories Extended release hydrocodone acetaminophen and related methods and uses thereof
MX2010009990A (es) * 2008-03-11 2010-12-15 Depomed Inc Formas de dosificación gástricas retentivas de liberación prolongada que comprenden combinaciones de un analgésico no opioide y un analgésico opioide.
MY161550A (en) * 2008-10-27 2017-04-28 Alza Corp Extended release oral acetaminophen/tramadol dosage form
US8021420B2 (en) * 2009-03-12 2011-09-20 Medtronic Vascular, Inc. Prosthetic valve delivery system
RU2012112552A (ru) * 2009-08-31 2013-10-10 Дипомед, Инк. Удерживаемые в желудке фармацевтические композиции для немедленного и продленного высвобождения ацетаминофена

Also Published As

Publication number Publication date
EP2704697B1 (en) 2018-09-12
TW201306881A (zh) 2013-02-16
US20140065213A1 (en) 2014-03-06
MX2013012918A (es) 2013-11-21
CA2835330A1 (en) 2012-11-15
CN103648486A (zh) 2014-03-19
CR20130572A (es) 2014-03-20
ZA201308316B (en) 2014-07-30
AP3878A (en) 2016-10-31
AU2012253834B2 (en) 2016-06-16
EP2704697A1 (en) 2014-03-12
WO2012154563A1 (en) 2012-11-15
EA201391643A1 (ru) 2014-07-30
AU2012253834A1 (en) 2013-12-05
NI201300116A (es) 2014-11-13
SG194605A1 (en) 2013-12-30
BR112013028668A2 (pt) 2017-01-24
AP2013007224A0 (en) 2013-11-30
EP2704697A4 (en) 2015-01-07
CL2013003176A1 (es) 2014-07-04
DOP2013000258A (es) 2014-07-15
GT201300270A (es) 2014-12-16
NZ617198A (en) 2016-01-29

Similar Documents

Publication Publication Date Title
SMT201700043B (it) Formulazioni di bendamustina
SMT201600049B (it) Formulazioni di apixaban
SMT201500054B (it) 2-Anilinobenzimidazolo-6-carbossammidi come agentianti-infiammattori
DK2787975T3 (da) Robuste formuleringer med kontrolleret frigivelse
DK3091029T3 (da) Anti-IL13-antistofformuleringer
BR112012030950A2 (pt) formulações de vacina
BR112013024527A2 (pt) pessário
CO6801637A2 (es) Formulaciones de anticuerpos
GT201200303A (es) Formulaciones farmacéuticas
DK3072505T3 (da) Testosteronformuleringer
BR112014004779A2 (pt) formulações de derivados de decitabina
CO6940426A2 (es) Formulaciones farmacéuticas
CO6870048A2 (es) Formulación herbicida mejorada
BR112014000015A2 (pt) formulação
CO6761402A2 (es) Formulaciones inmunosupresoras
DE112012003251A5 (de) Ausrücksystem
DE112012003262A5 (de) Ausrücksystem
BR112012022411A2 (pt) articulador
CO6801767A2 (es) Formulaciones de liberación sostenida de paracetamol
FR2975564B1 (fr) Charrue
BR112013003504A2 (pt) encosto traseiro unitário
DE112012003257A5 (de) Ausrücksystem
CO6960544A2 (es) Preparación de liberación sostenida
DK2672817T3 (da) Forbedrede insekticide formuleringer
DE112012003245A5 (de) Ausrücksystem

Legal Events

Date Code Title Description
FC Application refused